Pasithea Therapeutics (KTTA) Gross Profit (2022)
Historic Gross Profit for Pasithea Therapeutics (KTTA) over the last 1 years, with Q4 2022 value amounting to $242020.0.
- Pasithea Therapeutics' Gross Profit changed N/A to $242020.0 in Q4 2022 from the same period last year, while for Dec 2022 it was $373364.0, marking a year-over-year change of. This contributed to the annual value of $373364.0 for FY2022, which is 1697139.63% up from last year.
- Per Pasithea Therapeutics' latest filing, its Gross Profit stood at $242020.0 for Q4 2022.
- Over the past 5 years, Pasithea Therapeutics' Gross Profit peaked at $242020.0 during Q4 2022, and registered a low of -$1520.0 during Q2 2022.